Delivery Order SPE2DR25D1041-SPE2DR26FHP7C
- Not listed
- The Defense Logistics Agency awarded a $6,679 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for TYPHIM VI 25 MCG/0.5 ML syringes. The contract, which is a child of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX valued at $999,999,999 through December 2026), represents a competitively awarded, non-set-aside procurement with an ultimate completion date of October 21, 2025. Performance will take place at...
- The Defense Logistics Agency awarded a delivery order valued at $24,945.90 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the company's critical role as a pharmaceutical supplier to federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,449.50 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This competitive, firm fixed-price delivery order will be fulfilled at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. The award represents a small-value transaction typical of the company's extensive portfolio of pharmaceutical and medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $10.75K with a completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a small-value transaction within AmerisourceBergen's broader pharmaceutical distribution portfolio. The place of performance is located in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $3,080.32. This is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive...
- The Defense Logistics Agency awarded a $1,694.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 29, 2025, with completion targeted for September 2, 2025. This non-set-aside delivery order represents a small-value transaction under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,449.50 on June 6, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a $3,449.50 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 12, 2025, with completion scheduled for September 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger federal contract vehicle. The order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a $11,545.91 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on October 20, 2025, with an ultimate completion date of October 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply agreement with...
- The Defense Logistics Agency awarded a $3,339.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes (0.5 ML). This non-competitive, non-set-aside award is scheduled for completion by October 22, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction under AmerisourceBergen's larger federal contract portfolio supporting military and defense healthcare...
- SPE2DR25D1041Indefinite Delivery Contract
- SPE2DR25D1041-SPE2DR26FHP7CDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $17,854.65, with completion scheduled for October 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support to military healthcare systems and serves as the mechanism through which AmerisourceBergen supplies a broad spectrum of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities to federal customers including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability in fulfilling federal medical procurement requirements through open competition positions it as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.9k | 10/21/25 |